Previous 10 | Next 10 |
Zynex press release (NASDAQ:ZYXI): Q4 GAAP EPS of $0.23 beats by $0.04. Revenue of $40.37M (+57.7% Y/Y) misses by $0.95M. Q1 revenue to be in the range of $29M-$32M vs. consensus of $35.73M. FY2022 revenue is estimated in the range of $150M-$170M vs. consensus of $171.54M. For further detai...
Zynex Announces 2021 Fourth Quarter and Full Year Earnings PR Newswire ENGLEWOOD, Colo. , Feb. 24, 2022 /PRNewswire/ -- Zynex, Inc . (Nasdaq: ZYXI) an innovative medical technology company specializing in the manufacture and sale of non-invasive medical ...
Gainers: Creative Medical Technology (NASDAQ:CELZ) +33%. HOOKIPA Pharma (NASDAQ:HOOK) +18%. Zynex ZYXI +17%. AMN Healthcare Services (NYSE:AMN) +15%. ShockWave Medical (NASDAQ:SWAV) +10%. Losers: Baudax Bio (NASDAQ:BXRX) -11%. Nuvectis Pharma (NASDAQ:NVCT)...
Zynex (NASDAQ:ZYXI) rules out any material impact to the company topline after United Health Care dropped its coverage for the pain-related healthcare equipment company. In response to what it called a “short report,” Zynex (ZYXI) CEO Thomas Sandgaard said on Friday: "We do not ...
Zynex Anticipates No Material Change in Revenue from Switch in United Health Care Prescription Coverage PR Newswire ENGLEWOOD, Colo. , Feb. 18, 2022 /PRNewswire/ -- Zynex, Inc . (NASDAQ: ZYXI), an innovative medical technology company specializing in the manu...
Zynex (ZYXI -19.4%) stock is down significantly in afternoon trading and hit a 52-week low of $5.62 earlier. Year to date through yesterday, shares are down ~61%. Today's plunge may be related to UnitedHealth Group (UNH -0.9%) removing Zynex from its network as of Feb. 15. Seeking A...
We uncover strong evidence that UnitedHealthcare is removing Zynex from its network effective February 15, a seemingly material event undisclosed to investors. Zynex will lose its largest payor and only national commercial network if so, a critical relationship that represented high m...
Zynex, Inc. to Announce Fourth Quarter 2021 Financial Results PR Newswire ENGLEWOOD, Colo. , Feb. 8, 2022 /PRNewswire/ -- Zynex, Inc . ( Nasdaq: ZYXI ), an innovative medical technology company specializing in the manufacture and sale of non-invasive medi...
Zynex Adds Knee Bracing to Its Pain Management Division PR Newswire ENGLEWOOD, Colo. , Jan. 20, 2022 /PRNewswire/ -- Zynex, Inc. (NASDAQ: ZYXI), an innovative medical technology company specializing in the manufacture and sale of non-invasive medical devices for ...
Zynex Announces Increased Q4 2021 Adjusted EBITDA Estimate and 18% Order Growth PR Newswire ENGLEWOOD, Colo. , Jan. 18, 2022 /PRNewswire/ -- Zynex, Inc . (NASDAQ: ZYXI), an innovative medical technology company specializing in the manufacture and sale of non-...
News, Short Squeeze, Breakout and More Instantly...
Zynex Sets Second Quarter 2024 Earnings Call PR Newswire ENGLEWOOD, Colo. , July 17, 2024 /PRNewswire/ -- Zynex, Inc. (NASDAQ: ZYXI), an innovative medical technology company specializing in the manufacture and sale of non-invasive medical devices for pain manage...
Zynex Recognized as a Best Company to Work For by U.S. News & World Report and Top Workplaces Zynex Recognized as a Best Company to Work For by U.S. News & World Report and Top Workplaces PR Newswire ENGLEWOOD, Colo. , July 11, 2024 /PRNewswire/ -- Zy...